Skip to main content Help with accessibility Skip to main navigation

April 2022 updates to the website

The website has now been updated following April's LSCMMG

The following medicines have been added/updated:

Bempedoic acid with ezetimibe - updated background info

The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:

Empagliflozin - For treating chronic heart failure with reduced ejection fraction (NICE TA773)

Dapagliflozin - For treating chronic kidney disease (NICE 775)

Ozurdex (dexamethasone intravitreal implant) - for adult patients who have visual impairment due to diabetic macular oedema (DME) who are not pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy

Trimbow NEXThaler - COPD